Dr. Martens plc (LON:DOCS) Insider Acquires £149.38 in Stock

Key Points

• Insider Buying: Giles Wilson, an insider at Dr. Martens plc, purchased 194 shares at GBX 77 ($1.03) each, totaling £149.38 ($200.64) on August 11th.
• Stock Performance: As of Tuesday, Dr. Martens' stock traded at GBX 75.60 ($1.02), with a market capitalization of £733.90 million and a P/E ratio of 10.72.
• Analyst Ratings: Royal Bank of Canada lowered its price target for Dr. Martens from GBX 7,000 ($94.02) to GBX 6,000 ($80.59), maintaining a "sector perform" rating.

Dr. Martens plc (LON:DOCS - Get Free Report) insider Giles Wilson acquired 194 shares of the business's stock in a transaction that occurred on Monday, August 11th. The stock was purchased at an average price of GBX 77 ($1.04) per share, for a total transaction of £149.38 ($202.47).

Giles Wilson also recently made the following trade(s):

• On Friday, July 11th, Giles Wilson bought 194 shares of Dr. Martens stock. The shares were bought at an average cost of GBX 77 ($1.04) per share, with a total value of £149.38 ($202.47).
• On Wednesday, June 11th, Giles Wilson bought 189 shares of Dr. Martens stock. The shares were bought at an average cost of GBX 79 ($1.07) per share, with a total value of £149.31 ($202.37).

Dr. Martens Stock Performance

Shares of DOCS stock traded down GBX 0.71 ($0.01) during trading hours on Friday, reaching GBX 74.69 ($1.01). 331,271 shares of the company's stock were exchanged, compared to its average volume of 1,940,258. The company has a market cap of £725.06 million, a P/E ratio of 10.59, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11. The company's 50 day moving average is GBX 77.41 and its two-hundred day moving average is GBX 65.33. Dr. Martens plc has a 1 year low of GBX 43.02 ($0.58) and a 1 year high of GBX 85.41 ($1.16). The company has a debt-to-equity ratio of 127.27, a current ratio of 2.85 and a quick ratio of 1.13.

Dr. Martens (LON:DOCS - Get Free Report) last issued its earnings results on Thursday, June 5th. The company reported GBX 2.40 ($0.03) earnings per share (EPS) for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. Equities research analysts anticipate that Dr. Martens plc will post 2.5809394 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on DOCS shares. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating on shares of Dr. Martens in a research report on Friday, July 11th. Royal Bank Of Canada reduced their price objective on Dr. Martens from GBX 7,000 ($94.88) to GBX 6,000 ($81.32) and set a "sector perform" rating for the company in a research note on Monday, May 19th.

Dr. Martens Company Profile

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.